Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease

Canadian Journal of Kidney Health and Disease

Volumn 1, Issue 1, 2014, Pages 1-8

  Elliott, Meghan J ^a,e   Booth, Sarah L ^b   Hopman, Wilma M ^c   Holden, Rachel M ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b TUFTS UNIVERSITY   (United States)

^c KINGSTON GENERAL HOSPITAL   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

^e FOOTHILLS HOSPITAL   (Canada)

Author keywords

Chronic kidney disease; Hemodialysis; Osteocalcin; Phylloquinone; PIVKA; Vitamin K

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; DECARBOXYPROTHROMBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; PHYTOMENADIONE; SERUM ALBUMIN; TRIACYLGLYCEROL; VITAMIN K GROUP;

ADULT; AGE; AGED; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; END STAGE RENAL DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HEMODIALYSIS; HUMAN; MALE; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SMOKING; VERY ELDERLY; VITAMIN K DEFICIENCY; YOUNG ADULT;

EID: 84991037531     PISSN: None     EISSN: 20543581     Source Type: Journal    
DOI: 10.1186/2054-3581-1-13     Document Type: Article

References (36)

1. Collins AJ, Li S, Ma JZ, Herzog C: Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis 2001, 38(4 Suppl 1):S26-S29.
2. Tentori F: Mineral and bone disorder and outcomes in hemodialysis patients: results from the DOPPS. Semin Dial 2010, 23(1):10-14.
3. Raggi P, Bommer J, Chertow GM: Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. J Heart Valve Dis 2004, 13(1):134-141.
4. Chertow GM, Raggi P, McCarthy JT, Schulman G, Silberzweig J, Kuhlik A, Goodman WG, Boulay A, Burke SK, Toto RD: The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients. Am J Nephrol 2003, 23(5):307-314.
5. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM: Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007, 71(5):438-441.
6. Krasniak A, Drozdz M, Pasowicz M, Chmiel G, Michalek M, Szumilak D, Podolec P, Klimeczek P, Konieczynska M, Wicher-Muniak E, Tracz W, Khoa TN, Souberbielle JC, Drueke TB, Sulowicz W: Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant 2007, 22(2):515-521.
7. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003, 18(9):1731-1740.
8. Proudfoot D, Shanahan CM: Molecular mechanisms mediating vascular calcification: role of matrix Gla protein. Nephrology 2006, 11(5):455-461.
9. Krueger T, Westenfeld R, Ketteler M, Schurgers LJ, Floege J: Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney Int 2009, 76(1):18-22.
10. Schlieper G, Westenfeld R, Kruger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM, Djuric Z, Damjanovic T, Ketteler M, Vermeer C, Dimkovic N, Floege J, Schurgers LJ: Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 2011, 22(2):387-395.
11. Booth SL, Suttie JW: Dietary intake and adequacy of vitamin K. J Nutr 1998, 128(5):785-788.
12. Booth SL, Martini L, Peterson JW, Saltzman E, Dallal GE, Wood RJ: Dietary phylloquinone depletion and repletion in older women. J Nutr 2003, 133(8):2565-2569.
13. Booth SL, Lichtenstein AH, O'Brien-Morse M, McKeown NM, Wood RJ, Saltzman E, Gundberg CM: Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am J Clin Nutr 2001, 74(6):783-790.
14. Booth SL, Broe KE, Peterson JW, Cheng DM, Dawson-Hughes B, Gundberg CM, Cupples LA, Wilson PW, Kiel DP: Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab 2004, 89(10):4904-4909.
15. Szulc P, Chapuy MC, Meunier PJ, Delmas PD: Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 1996, 18(5):487-488.
16. Szulc P, Arlot M, Chapuy MC, Dubeouf F, Meunier PJ, Delmas PD: Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994, 9(10):1591-1595.
17. Kohlmeier M, Saupe J, Shearer MJ, Schaefer K, Asmus G: Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int 1997, 51(4):1218-1221.
18. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD: Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997, 82(3):719-724.
19. Kato A, Yasuda H, Togawa A, Yamamoto T, Yonemura K, Maruyama T, Maruyama Y, Hishida A: Measurement of des-gamma-carboxy prothrombin levels in hemodialysis patients positive for anti-hepatitis virus C antibody. Clin Nephrol 2002, 58(4):296-300.
20. Westenfeld R, Krueger T, Schlieper G, Cranenburg EC, Magdeleyns EJ, Heidenreich S, Holzmann S, Vermeer C, Jahnen-Dechent W, Ketteler M, Floege J, Schurgers LJ: Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 2012, 59(2):186-195.
21. McGillion M, L'Allier PL, Arthur H, Watt-Watson J, Svorkdal N, Cosman T, Taenzer P, Nigam A, Malysh L: Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement. Can J Cardiol 2009, 25(7):399-401.
22. Davidson KW, Sadowski JA: Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorimetric detection. Methods Enzymol 1997, 282:408-421.
23. Gundberg CM, Nieman SD, Abrams S, Rosen H: Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 1998, 83(9):3258-3266.
24. Sokoll LJ, Sadowski JA: Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr 1996, 63:566-573.
25. Pilkey RM, Morton AR, Boffa MB, Noordhof C, Day AG, Su Y, Miller LM, Koschinsky ML, Booth SL: Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 2007, 49(3):432-439.
26. Holden RM, Iliescu E, Morton AR, Booth SL: Vitamin K status of Canadian peritoneal dialysis patients. Perit Dial Int 2008, 28(4):415-418.
27. Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL: Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 2010, 5(4):590-597.
28. Crosier MD, Peter I, Booth SL, Bennett G, Dawson-Hughes B, Ordovas JM: Association of sequence variations in vitamin K epoxide reductase and gamma-glutamyl carboxylase genes with biochemical measures of vitamin K status. J Nutr Sci Vitaminol 2009, 55(2):112-119.
29. Booth SL, Golly I, Sacheck JM, Roubenoff R, Dallal GE, Hamada K, Blumberg JB: Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. Am J Clin Nutr 2004, 80(1):143-148.
30. Schurgers LJ, Vermeer C: Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta 2002, 1570(1):27-32.
31. Fusaro M, Noale M, Viola V, Galli F, Tripepi G, Vajente N, Plebani M, Zaninotto M, Guglielmi G, Miotto D, Dalle Carbonare L, D'Angelo A, Naso A, Grimaldi C, Miozzo D, Giannini S, Gallieni M, Vitamin K Italian (VIKI) Dialysis Study Investigators: Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study. J Bone Miner Res 2012, 27(11):2271-2278.
32. Cranenburg EC, Schurgers LJ, Uiterwijk HH, Beulens JW, Dalmeijer GW, Westerhuis R, Magdeleyns EJ, Herfs M, Vermeer C, Laverman GD: Vitamin K intake and status are low in hemodialysis patients. Kidney Int 2012, 82(5):605-610.
33. Institute of Medicine: Dietary reference intakes for vitamin A, vitamin K1, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington, DC: The National Academies Press; 2001.
34. Binkley NC, Krueger DC, Kawahara TN, Engelke JA, Chappell RJ, Suttie JW: A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am J Clin Nutr 2002, 76(5):1055-1060.
35. Westhofen P, Watzka M, Marinova M, Hass M, Kirfel G, Muller J, Bevans CG, Muller CR, Oldenburg J: Human vitamin K 2,3-epoxide reductase complex subunit 1-like 1 (VKORC1L1) mediates vitamin K-dependent intracellular antioxidant function. J Biol Chem 2011, 286(17):15085-15094.
36. Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, Vermeer C, Choukroun G, Massy ZA: The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol 2010, 5(4):568-575.